Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

HISTORICAL FACTS: 2 - The Untold Story

4 Marijuana Stocks to Avoid Like the Plague

While marijuana legalization has been rising, the industry is witnessing increased regulations. Moreover, the sector’s revenues have been declining recently. Hence, marijuana stocks Tilray Brands (TLRY), Canopy Growth (CGC), Sundial Growers (SNDL), and Aurora Cannabis (ACB) might be best avoided, given their weak fundamentals and negative profit margins. Keep reading.

StockNews.com

Why Is SNDL Trading Higher Today?

SNDL Inc. (NASDAQ: SNDL) shares are trading 8.85% higher at $2.83 per share during Monday’s pre-market session.

Benzinga

The Valens Announces Mailing And Filing Of Circular For Special Meeting Of Shareholders To Approve Arrangement With SNDL

The Valens Company Inc.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Valens Shares Slightly Up On Declining Quarterly Revenue

The Valens Company Inc.

Benzinga

Update On Cannabis M&A: Aurora, TerrAscend, SNDL, Curaleaf, And… A Costly Preferred Stock Raise?

On Thursday, analyst Pablo Zuanic from Cantor Fitzgerald offered an industry update on four recent M&A deals and Glasshouse Series B Preferred stock issuance.

Benzinga

SNDL To Buy Superette Assets Including 6 Retail Stores, Enters Into A Bid Agreement

SNDL Inc. (NASDAQ: SNDL) has entered into an agreement of purchase and sale with Superette Inc., pursuant to which it proposes to acquire substantially all of the business and assets of Superette through a hybrid asset purchase and 'reverse vesting' transaction.

Benzinga

SNDL To Buy Valens For $105M In Stock Creating Cannabis Behemoth

SNDL Inc. (NASDAQ: SNDL) and The Valens Company Inc.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Reddit's Favorite Weed Stock SNDL Posts Staggering Revenue Growth, But Cantor Lowers Price Target

SNDL Inc.

Benzinga

Canopy Growth Stock Slides, Analysts Divided

Canopy Growth (NASDAQ: CGC) experienced a severe sell-off, as it currently trades at the very bottom of its 52-week range. It's almost near the bottom on shorter time spans, including the 50-day range. The stock is currently down -74.62%, severely underperforming the S&P 500 with a loss of -18.25%.

Benzinga

2 Stocks Trading Under $3: Are They Really Bargains?

Rising inflationary pressure, aggressive interest rate hikes, and increasing odds of a recession have led major stock market indices to witness massive sell-off lately. FuboTV (FUBO) and Sundial Growers (SNDL) have lost significantly and are currently trading below $5. However, considering their weak fundamentals, it could be wise to avoid…

StockNews.com

Here's Why Investors Should Keep An Eye On Sundial Stock, Analyst's Thoughts Post Q1 Earnings

On Monday, Canadian cannabis LP Sundial Growers Inc. (NASDAQ: SNDL) released its

Benzinga

Sundial Growers Revenue Grew 63% In Q4 2021 To $17.63M YoY

Sundial Growers Inc. (NASDAQ: SNDL) reported its financial and operational results for the full year and fourth quarter ended December 31, 2021.

Benzinga

Sundial Growers Plans To Report Earnings By April 29, Provides MCTO Status Update

Sundial Growers Inc. (NASDAQ: SNDL) expects to file its audited consolidated financial statements for the year ended December 31, 2021, annual management’s discussion and analysis for the same period, annual information form for the same period and management certific

Benzinga

Better Buy for 2022: Sundial vs. Canopy Growth

In this article I will analyze and compare Sundial Growers (SNDL) and Canopy Growth (CGC) to determine which cannabis stock is currently the better investment.

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

Do Sundial Growers and Clever Leaves Deserve a Place in Your Cannabis Portfolio?

Cannabis stocks, such as Sundial Growers (SNDL) and Clever Leaves (CLVR), are trading significantly lower compared to record highs. While the two companies might look attractive to contrarian investors, you need to take a closer look at the financials to make a long-term investment decision.

Benzinga

BZ Chart Of The Day: Sundial Growers Smashes Into Wall Of Resistance

Once again, shares of Sundial Growers Inc. (NASDAQ: SNDL) have reversed after hitting resistance at the important 90-cent level. The same thing happened in August and then again in November.

Benzinga

Chart Wars: Between Sundial And Tilray, Which Marijuana Stock Could Smoke Shorts First?

Sundial Growers Inc (NASDAQ: SNDL) was trading slightly higher on Wednesday, while Tilray, Inc (NASDAQ: TLRY) was trading down about 2%.

StockNews.com

2 Surprising Canadian Cannabis Stocks That Rallied in the Past Month

Though the S&P 500 is only up 1% in the past month, Canadian cannabis stocks Sundial Growers (SNDL) and Flora Growth (FLGC) have gained 8.7% and 16.6%, respectively.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Sundial Growers Granted 180-Day Extension By NASDAQ To Regain Compliance With Minimum Bid Rule

Sundial Growers Inc. (NASDAQ: SNDL), has received an extension of 180 calendar days to regain compliance with NASDAQ's minimum bid price requirement.

StockNews.com

3 Beaten-Down Cannabis Stocks That Will More Than Double, According to Wall Street

Cannabis stocks have plunged so far this year due to broader market selloff and delays in cannabis federal legislation. However, given the bolstering growth outlook for this industry, Wall Street analysts are betting on Curaleaf Holding (CURLF), Trulieve Cannabis (TCNNF), Sundial Growers (SNDL), and HEXO Corp. (HEXO) to surge in…

StockNews.com

4 Overvalued Cannabis Stocks Investors Should Continue to Avoid

The cannabis industry witnessed solid growth last year on a legalization wave and increasing demand for innovative cannabis products. But while the industry is expected to maintain its momentum this year, some cannabis stocks are trading at lofty valuations despite their companies’ relatively weak growth prospects. So, we think overvalued…

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Canopy Growth Corporation

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.